We’re building ultrasound catheters for rapid clot disruption and
microvascular protection during PCI.
When there's no solution
1 out of 2 heart attack patients still develops microvascular obstruction (MVO), blockage in the heart’s smallest blood vessels — even after timely treatment. MVO remains a major driver of poor recovery, heart failure, and long-term mortality after heart attack treatment.
Our Solution
CardioCare
A first-in-class re-clinically validated catheter solution for PCI
Breakthrough research originating at ETH Zurich
Proprietary, patent-pending catheter technology
Seamlessly integrates into PCI workflows
Strategic medtech partnerships and investor inquiries
SonoRobotics develops catheter-based ultrasound technology for thrombus disruption and microvascular protection in PCI workflows.
Years of Research
Patents & Pending patent
